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Abstract
A major long-term goal of systems neuroscience is to identify the different roles of neural
subtypes in brain circuit function. The ability to causally manipulate selective cell types is critical
to meeting this goal. This protocol describes techniques for optically stimulating specific
populations of excitatory neurons and inhibitory interneurons in vivo in combination with
electrophysiology. Cell type selectivity is obtained using Cre-dependent expression of the light-
activated channel Channelrhodopsin-2. We also describe approaches for minimizing optical
interference with simultaneous extracellular and intracellular recording. These optogenetic
techniques provide a spatially and temporally precise means of studying neural activity in the
intact brain and allow a detailed examination of the effect of evoked activity on the surrounding
local neural network. Injection of viral vectors requires 30–45 min, and in vivo electrophysiology
with optogenetic stimulation requires 1–4 h.
INTRODUCTION
One of the main goals of systems neuroscience is to understand the architecture and function
of neural circuits. These circuits consist of a complex network of varying neural subtypes. In
the cortex and hippocampus, local neural circuits are comprised of excitatory neurons,
which are often pyramidal cells, and several classes of inhibitory interneurons1–5. The
development of technologies to regulate the activity of specific types of cells is key to
understanding how they contribute to local network activity and overall brain function in
vivo. This control has recently become feasible with the advent of optogenetics, the optical
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control of neural activity by artificial incorporation of light-sensitive proteins into cell
membranes. This approach provides a reliable method for stimulating neural activity in
mammalian tissue in vitro6–8 and in vivo9–15. The use of optogenetic tools to stimulate or
suppress the activity of neural populations has potential applications for both experimental
and therapeutic approaches. Recent studies have highlighted the use of cell-type-specific
expression of the light-sensitive cation channel Channelrhodopsin-2 (ChR2), which is
activated by ~470 nm light, as a tool for exploring the functional role of inhibitory
interneurons in gamma oscillations in the intact brain12 and information processing in vitro8.
Previous experiments12 required efficient viral transduction, cell-type-specific expression of
light-sensitive channels and in vivo integration of optical stimulation with extracellular and
intracellular recording techniques. This paper was one of the first to realize the promise of
optogenetics to test hypotheses about the roles of specific neural populations in the in vivo
mammalian neocortex. Because there is broad interest in applying this approach in vivo to
the cortex or closely related systems, such as the hippocampus, we provide here a detailed
description of methods.
Combined optical stimulation and electrophysiological recordings in vivo
The use of light activation for assessing neural network dynamics requires simultaneous
application of neural recording techniques and extrinsic network modulation. One specific
challenge raised by this combination is that optical stimulation can induce various electrical
artifacts during such recordings. These artifacts could emerge from causes ranging from
possible photoelectric effects to temperature-dependent effects on electrode conduction
properties. These challenges have proven relatively easy to circumvent in vitro but have
interrupted effective recording of field potentials— the most commonly used marker for
cortical dynamics— in recent optogenetic studies in vivo13. This protocol describes optically
induced artifacts in the mouse neocortex and outlines means for minimizing their impact.
Cell-type-specific expression of light-activated channels
A variety of approaches can be used to achieve insertion of light-activated elements into
neurons that are otherwise not optically sensitive, including constitutive expression in
transgenic mice16, in utero electroporation14 and use of viral approaches both with and
without associated use of a Cre-loxP system8,11,12. These methods have strengths and
weaknesses in generating cell-type-specific expression. Generation of transgenic mice
expressing cell-type-specific ChR2 is effective14, but costly and time-consuming. In utero
electroporation can be targeted to general cell classes by varying the site and prenatal day of
treatment17–22. This early surgery has the advantage of allowing maximal recovery of the
pups across development and of providing at least some cell-type specificity in any given
model species. However, this approach requires an invasive surgery in utero in which probes
are inserted into the fetal brain, which can have negative scientific and practical implications
for a given experiment. Most importantly, cell-type specificity of expression is limited to the
resolution provided by knowledge of cell birth date and relatively broad localization to the
targeted germinal zones23.
The most commonly used strategy to date for the expression of ChR2 in brain tissue is
through viral transduction. Viral vectors driving ChR2 expression can be delivered directly
into specific brain regions with robust transduction efficacy and limited tissue damage.
Adeno-associated viruses (AAVs) provide extensive spatial spread and high expression
levels12,24. Lentiviral vectors expressing light-activated channels have also been used in the
cortex but do not appear to spread as effectively as AAV vectors7,13–15. Further, recent
evidence suggests that lentiviruses preferentially transduce excitatory neurons25 and thus
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appear to be applicable for targeting this cell population but may not be suitable for targeting
inhibitory interneurons.
Targeted expression of genes to specific cell types can be robustly achieved with the Cre–
loxP system. Recent studies have used ‘double-floxed’ inverted open reading frame (DIO)
viral vectors to achieve high specificity and expression levels8,11,12,26. We have recently
used the viral vector AAV DIO-ChR2-mCherry (AAV DIO ChR2-mCherry) in knock-in
and transgenic Cre mice to target the expression of ChR2 to defined neuronal populations
(Fig. 1a)12. In AAV DIO ChR2-mCherry, two incompatible loxP variants flank an inverted
version of ChR2 fused to the fluorescent marker mCherry. In the presence of Cre, a
stochastic recombination of either loxP variant takes place27, resulting in the inversion of
ChR2-mCherry into the sense direction, followed by expression of the light-activated
channels. Cre-dependent expression of light-activated channels or other genes is particularly
well suited for targeting expression to cell types that lack identified promoter sequences. In
most cases, cellular promoters are not yet identified or are incompatible for use in viruses
because of size limitations. Cellular promoters may also fail to render enough specificity or
sufficient expression levels for meaningful optogenetic studies.
Successful use of optogenetic techniques relies on sufficient expression levels of the light-
activated channels, which limits the use of small promoter elements8. To circumvent issues
of specificity and expression levels, the vector AAV DIO ChR2-mCherry depends on a
strong and general promoter (EF1α, elongation factor 1α), and cell-type specificity is
conferred by the unique Cre expression pattern of each transgenic mouse line8,11,12. The
inverted strategy of AAV DIO ChR2-mCherry eliminates the need for a polyadenylation
stop-cassette in the viral construct, as the presence of Cre followed by recombination is
needed for inversion of ChR2-mCherry into the sense direction, leading to expression of the
opsin. For a thorough explanation of the double-floxed inverted strategy, see reference 12.
Traditionally, Cre-dependent viral vectors are constructed with a loxP-flanked
transcriptional stop cassette preceding the gene of interest, but the size limitations of the
viral vectors exclude the use of large stop cassettes. As a result, only smaller stop cassettes
are possible in viral vectors, leading to documented leakiness and expression of the gene of
interest in the absence of Cre6,8.
The application of optogenetics to in vivo electrophysiology has opened up an
unprecedented possibility for analysis of neural circuits by the characterization of cell-type-
specific functions. The combination of several publicly available mouse lines with Cre
expression in defined neuronal populations with AAV viruses conferring Cre-dependent
expression of light-activated channels provides a new experimental framework for the
detailed characterization of activity in the intact brain. The techniques described here
provide an approach for navigating the many challenges of cell-type-specific targeting,
successful viral delivery and uncontaminated electrophysiological recording during optical
stimulation, and may be used to facilitate studies of the role of specific cell types in
mammalian brain function.
Experimental design
Cell type targeting, expression construct and virus—The use of a viral DIO
construct allows for expression of ChR2 exclusively in the subpopulation of neurons that
expresses Cre recombinase. A number of transgenic, BAC and knock-in mouse lines, now
commercially available, express Cre in specific populations of excitatory neurons (e.g.,
CW2, T29-1, T29-2, respectively) or inhibitory interneurons (e.g., PV-Cre). The specificity
of ChR2 expression conferred by the DIO construct is very high (Fig. 1b,c)8,11,12. However,
individual Cre lines exhibit varying degrees of cell-type-specific Cre expression, which can
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result in the expression of ChR2 in mixed neuronal populations. A fluorescent tag, such as
mCherry fused to ChR2, allows post-hoc identification and mapping of ChR2-expressing
cells for direct assessment of the specificity of expression (Fig. 1b,c). Control injections of
the floxed viral construct should be made in mice that do not express Cre recombinase to
confirm that the expression of ChR2-mCherry does not occur.
The selection of a viral vector is important, as different viruses and virus serotypes exhibit
different cellular tropisms28–31. Both AAV8,10–12 and lentivirus7,13–15 have been
successfully used for expression of light-activated channels in several brain areas, including
the cortex and hippocampus. In addition, the degree of viral spread from the injection site
can vary widely with virus29 and tissue type transduced24. One advantage of AAV is the
broader spatial spread of ChR2 expression around the injection site. We routinely observe
expression over a distance of up to 2 mm of cortical tissue (Fig. 1b)12. The protocol outlined
here specifies the use of an AAV vector, but may be successfully used with other virus
types.
Injection parameters—Slow injection of small volumes of virus is critical for effective
transduction of neural tissue with minimal damage. The post-injection wait time sufficient
for maximal expression levels of ChR2 varies with virus type. We have observed high levels
of ChR2 6 d after cortical injection of AAV DIO vectors12, with expression remaining high
for at least several months after the initial injection.
Electrophysiology—Single extracellular electrodes or multielectrode arrays may be
placed several hundred microns away from the injection site, ensuring that the recordings
are made from transduced tissue that is undamaged by the initial viral delivery (Fig. 2a–c).
Similarly, ChR2 stimulation works well in conjunction with intracellular recordings in vivo
(Fig. 2d). The latency to light-evoked spikes and the precision of evoked spike timing will
vary with cell type, region of the cell stimulated (e.g., soma versus axon) and light stimulus
intensity12. In addition, for anesthetized experiments, physiological state should be
monitored by several means including simultaneous electroencephalogram recording, as the
effects of light stimulation on spike rate and local field potential (LFP) signals will vary with
anesthesia depth. Direct laser light on metal electrodes can cause electrical artifacts that
obscure LFP signals, but these can be reduced by several measures (see
TROUBLESHOOTING and Fig. 3). Control recordings should be made from untransduced
tissue to confirm that light-evoked neural activity is only observed in tissue expressing
ChR2.
Light stimulation parameters—Light spreads in an approximate cone from the point
source at the tip of the optical fiber, and light power from a fiber at the surface of the brain
decreases with tissue depth32. Light intensity is usually measured in mW mm− 2, and a safe
range for in vivo experiments is up to ~75 mW mm− 2 for short pulses (~0.5 to 50 ms). We
have observed significant tissue damage in the cortex immediately under the optical fiber
from sustained stimulation (>500 ms duration) at levels above 100 mW mm− 2. Light can be
applied through the mouse dura or thinned skull, and surface positioning of the optical fiber
allows effective stimulation throughout supragranular and granular cortical layers in the
mouse sensory cortex (~500 μm depth). Alternatively, optical fibers of smaller diameter
(50–100 μm) can be placed in the brain for stimulation of deeper cells or smaller volumes of
tissue. It is important to consider the duration and strength of the light pulse, as continuous
light application can cause abnormal levels of neural activity and excitotoxicity. Power
transmitted by the fiber will vary with fiber type (multimode or single-mode) and the spread
of light from the fiber is partially determined by the numerical aperture (NA), with low NA
corresponding to a narrow angle and high NA corresponding to a larger angle. Power
delivered to the tissue (in mW mm− 2) will also vary with the radius (r) of the fiber, as the
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area of the initial cross-section of the light at the tip of the fiber increases as πr2. Power
decreases with distance from the light source32, giving varying effective intensities at
different cortical depths.
MATERIALS
REAGENTS
• Experimental animals (mice) ! CAUTION Use of live rodents must conform to
national and institutional rules and regulations.
• AAV of desired serotype at titer of ~1012 (can be stored for ~1 year at − 80 °C)
• Dye marker (Fast Green 2.5%, Electron Microscopy Sciences, cat. no. 26364-05)
• Sterile saline (NaCl 0.9%, Henry Schein, cat. no. 1200721)
• Anesthetic (Isoflurane, Henry Schein, cat. no. 2091966)
• Local anesthetic (Lidocaine 1%, Henry Schein, cat. no. 2586460)
• Analgesic (Buprenorphine, Henry Schein, cat. no. 1048721)
• Iodine-based wash (Betadine, Henry Schein, cat. no. 6906950)
• Cyanoacrylate glue (Vetbond Tissue Adhesive, Henry Schein, cat. no. 7003449)
• Eye lubricant (Puralube Ointment, Henry Schein, cat. no. 4725942)
• Mineral Oil (White, Light, Fisher Scientific, cat. no. O121-1)
• Tank of compressed O2
EQUIPMENT
• Isoflurane vaporizer (Harvard Apparatus, cat. no. 728130)
• Stereotaxic frame with anesthesia head holder and arms for electrode holders
(David Kopf, Model no. 930, Model no. 1760-61, Model no. 1460 and Model no.
923-B)
• Stereotaxic injector system (Stoelting QSI, Stoelting, cat. no. 53311)
• Heating blanket (Harvard Apparatus, cat. no. 507220F)
• Surgical tools (Fine Science Tools)
• Microfils (26g MicroFil, World Precision Instruments, cat. no. CMF26G6L)
• High-speed dental drill (Classic High-Speed Handpiece, Johnson- Promident)
• Drill bits (Johnson-Promident, cat. no. 1/4FG)
• Hair trimmer (Harvard Apparatus, cat. no. 525204)
• Pipette Puller (Sutter Instrument, Sutter Model P-97)
• Electrophysiology equipment for extracellular or intracellular recordings
• Extracellular electrodes (e.g., single tungsten electrodes, FHC; prefabricated
tetrode arrays, NeuroNexus Technologies; or twisted wire stereotrodes or tetrodes)
• Graduated borosilicate glass capillaries (Wiretrol I, Drummond; Calibrated
Micropipette, 10 μl size, Fisher Scientific)
• ~473 nm laser (e.g., Opto Engine LLC or IkeCool)
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• Breadboard (1/2″ Solid Aluminum Breadboard, Thorlabs, part no. MB1824)
• Posts (Thorlabs; 1/2″ posts)
• FiberPort Coupler (FiberPort, part no. PAF-SMA-5-A and HCP-L Bracket Mount;
Thorlabs)
• Optical Fiber (Thorlabs, BFH22-200 or BFH37-200)
• SMA connectors (Fiber SMA Connectorization Kit, SMA 905 connectors,
Thorlabs)
• Optical power meter (PM100D power meter, S120C power sensor, NE03A optical
density filter, Thorlabs)
REAGENT SETUP
Virus—Add a small amount (~0.05 to 0.1 μl) of Fast Green to 1 μl of the virus solution.
EQUIPMENT SETUP
Surgical tools—For injection surgeries, tools and workspace should be sterilized
according to institutional procedures.
Injection pipettes—Glass injection pipettes should be pulled to have a shank of several
millimeters and a relatively sharp tip with a diameter of ~40 to 80 μm. Using a syringe and a
MicroFil, the pipette should be completely filled with mineral oil to the tip. Break the tip
back slightly with forceps or scissors to allow free flow of the oil.
Stereotaxic setup—At least two manipulators are necessary: one to hold the recording
electrodes and another to position the optical fiber. For extracellular recordings, these can
both be fairly coarse, but intracellular recordings require high-resolution manipulators with
specialized pipette holders. The animal should be firmly placed in the stereotaxic apparatus,
with the head appropriately positioned for the precise use of landmarks for injections and
recordings. Connect the output of the isoflurane vaporizer to the input on the anesthesia head
holder.
Anesthesia setup—The animal should be anesthetized initially with a small dose of
isoflurane administered in an induction chamber or small container, as determined by
institutional policy. The animal should then be placed in the stereotaxic frame with the nose
in the anesthesia head-holder with (at ~0.5 to 1 liter min− 1) running to the apparatus. Initial
isoflurane in O2 isoflurane levels after induction may be as high as 2% and may be lowered
over the course of surgery to ~1% as the animal reaches a stable plane of anesthesia.
Optics setup—The laser and optics parts should be stably attached to the breadboard so
that the laser beam hits the center of the fiberport. An SMA connector should be attached to
the optical fiber of the desired core diameter and the fiber should then be connected to the
output connector on the fiber port. Before starting any stimulation, the input–output function
of the laser should be tested with the optical power meter. Many lasers produce variable
light output depending on voltage input, and it is important to carefully calibrate the light
intensity at the tip of the fiber (mW mm− 2) at each input voltage level. Only a low total
output power may be needed to achieve ChR2 activation. For instance, 2 mW at the tip of a
200-μm core diameter fiber corresponds to 63.7 mW mm− 2, well above the minimal
effective range for in vivo stimulation. Mount the fiber on an electrode manipulator for
positioning in the craniotomy (Fig. 2a).
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PROCEDURE
Virus injection ● TIMING 30–45 min
1| Anesthetize the animal and place it in the stereotaxic apparatus on a heating
blanket (37 °C) in a sterile surgical environment.
▲ CRITICAL STEP Test the animal’s reflexes to determine that a surgical
level of anesthesia has been reached before proceeding with surgery.
2| Using hair trimmers, shave the scalp above the area of interest.
3| Raise the skin with forceps and administer several small subcutaneous injections
of lidocaine or a similar local anesthetic. Wait 2–3 min for injections to take
effect.
4| Using a fresh scalpel blade, make a single incision through the skin. Ensure that
the incision runs far enough along the anterior–posterior axis to expose
stereotaxic markers. Gently push aside connective tissue on top of the skull as
needed for clear viewing.
5| Using stereotaxic coordinates, mark the intended site of virus injection.
6| Make a single burr-hole in the skull with the drill at the injection site. Stop when
the drill bit reaches the bottom of the skull. The total diameter of the burr hole
should be no more than 100 μm. A thin layer of skull may remain. Using a
syringe needle, remove a small piece of any remaining skull so that the dura can
be seen. The opening in the dura should be not more than several tens of
microns in diameter. Flush the site with sterile saline while drilling to remove
bone dust and control heat generation.
▲ CRITICAL STEP Too much pressure can cause the drill to penetrate too far
and directly damage the dura and underlying tissue, causing cellular
degeneration post-injection. The drill head should never touch the dura.
7| Fill the tip of the injection pipette with ~1 μl of virus tinted with Fast Green and
position the pipette over the burr hole. Lower the pipette until the tip touches the
exposed dura and use this point as the ‘zero.’ Lower the pipette tip through the
dura to the desired depth in the brain tissue.
8| Inject virus at a rate of not more than 0.1 μl min−1. When the injection is
completed, allow a minimum of 10 additional minutes rest time before
beginning to retract the pipette from the brain. Retract the pipette slowly, in two
stages, allowing another 5 min rest time at the halfway point.
▲ CRITICAL STEP Injecting virus rapidly or withdrawing the pipette too fast
can cause the fluid to flow out of the injected site up the track, reducing the
effective volume.
▲ CRITICAL STEP Using the Fast Green as a marker, ensure that the correct
volume of virus is expelled through the pipette.
9| Pull the edges of the skin together and clean lightly with Betadine. While
holding the edges of the incision together, apply small amounts of cyanoacrylate
glue to seal. The burr hole does not need to be covered or filled.
10| Allow the animal to recover from the anesthetic and treat with analgesic (e.g.,
Buprenorphine) for at least 3 d after injection surgery.
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■ PAUSE POINT For neocortical and hippocampal injections in PV-Cre and
CW2-Cre mice, 6 d after injection was sufficient delay to produce effective
expression levels of ChR2 in interneurons and excitatory neurons, respectively.
Longer wait times will allow for higher expression of ChR2 and may be
necessary for a desired expression level in other brain areas.
Stimulation and recording of ChR2-expressing neurons ● TIMING 1–4 h
11| Anesthetize the animal and give local anesthetic as in Steps 1 and 3. Using
forceps, remove any remaining cyanoacrylate glue from the skin. Reapply local
anesthetic throughout the experiment.
12| Using the initial burr hole as a marker, make a clean craniotomy next to the
injection site. One side of the craniotomy may abut the injection site, but the
targeted area for recording should be at least 200 μm away from the injection
site to reduce the potential for recording from damaged tissue. The craniotomy
should be large enough to allow positioning of both the optical fiber and the
electrodes.
▲ CRITICAL STEP Disrupting the dura or causing direct brain tissue damage
with the drill will result in bleeding, obscuring the placement of electrodes and
reducing laser light transmission.
13| Make a small incision in the dura to allow the placement of electrodes, being
careful to not cause bleeding. This opening can be accomplished with a fine
syringe tip (29 gauge), fine forceps or fine scissors. Lightly tapping a fine
syringe tip orthogonal to a hard surface can produce a hook that can facilitate
snagging the dura.
14| Place the extracellular electrodes in the brain tissue at the desired angle (Figs. 2a
and 3c) and depth by lowering slowly. If using an array of electrodes or a large
single electrode, allow tissue to recover from electrode placement for up to 30
min before stimulating or recording. (If using intracellular electrodes, perform
Step 15 first.)
15| Place the optical fiber close to the electrodes so that the cut surface of the bare
fiber is flat against the surface of the dura. Ensure that there is no blood between
the fiber ending and the dura.
16| Give short light pulses (~1 to 10 ms duration at 20–70 mW mm−2) to evoke
activity from ChR2-expressing cells (Figs. 2b and 3b,c).
? TROUBLESHOOTING
● TIMING
Steps 1–10, virus injection: ~30 to 45 min
Steps 11–16, stimulation and recording of ChR2-expressing neurons: ~1 to 4 h
? TROUBLESHOOTING
No light-evoked activity (Step 16)
1. Ensure that ChR2 is being expressed by performing histology. Identify cells
expressing light-activated channels by the presence of the fluorescent protein fused
to ChR2 (Fig. 1b,c).
2. Viral transduction does not always spread evenly around the injection site. We have
observed a larger anterioposterior than mediolateral spread when using an AAV
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DIO vector in somatosensory cortex. Move electrodes and optical fiber in small
(~20 to 50 μm) steps around the injection site.
3. Light levels may not be sufficient to evoke activity. Test the light power at the end
of the optical fiber to make sure that sufficient light is penetrating the brain. Ensure
that the bare end of the fiber is cut cleanly and is not obscured by blood.
4. If the targeted cell type is sparsely represented in the tissue, a careful search may be
necessary to find ChR2-expressing cells.
5. ChR2-expressing cells may be located too deep to stimulate with an optical fiber
placed at the surface of the brain. In this case, a small diameter optical fiber can be
lowered into the brain tissue in the same manner as an electrode. Take care to
minimize bleeding, as blood can reduce laser light transmission.
Electrical artifacts (Step 16)
Several studies12,13,33 have recently reported electrical artifacts produced by the laser beam
striking metal (Fig. 3). These effects can result from laser light hitting the tip of a metal
electrode, a ground electrode or a silver wire in a glass pipette and are proportional in size to
the total laser power and the amount of exposed metal. The artifacts differ from evoked
neural activity, in that their onset is exactly aligned with the light onset (Fig. 3a, inset),
rather than showing a delay of several milliseconds. In addition, light-induced artifacts
typically show an onset ramp that continues for the duration of a stimulus if that stimulus is
short (e.g., 1 ms) and have a slower offset time constant (e.g., 2–10 ms decay time in
response to a 1-ms light pulse). These artifacts can contaminate both LFP recordings and
intracellular traces.
Several strategies can be used to minimize optical contamination of electrophysiological
recording in vivo. The primary goal is to limit metal exposure to light by limiting the
duration of the light pulse and minimizing the total exposed metal surface. These light-
mediated artifacts have relatively little impact on extracellular action potential signals and
are a less significant issue if neither field potential nor intracellular recordings are needed13.
If field potential or intracellular signals are desired, one optimal approach is to use glass
electrodes with a more distal metal wire insert that is not contacted by the light, a strategy
typically used in slice or culture recordings. For field potential recordings made with glass
electrodes, further adding a non-reflective, opaque coating to the glass will reduce light
transmission to the silver wire in the electrode (Fig. 3a,b). We have found both non-
reflective acrylic paint and nitrocellulose-based lacquers to be effective in blocking light
transmission and completely eliminating measurable optical artifacts. Although this solution
is useful, many in vivo applications require metal electrodes, as they are more optimal for
chronic recording and more typically used for recordings requiring placement of multiple
sites in close proximity (e.g., stereotrodes or tetrodes). We have found that tungsten
electrodes with small exposed tip surfaces (e.g., twisted wire stereotrodes or tetrodes with
wire diameters < 20 μm) show smaller optically induced artifacts than do tungsten
electrodes with larger exposed metal tips (e.g., standard electrodes from FHC). In
simultaneous local field recordings, optically induced artifacts on twisted wire stereotrodes
(12.5 μm wire diameter) were 84.6 ± 16.3% smaller than those on adjacent commercially
produced single electrodes (FHC tungsten electrode, 75 μm diameter, standard fine tip).
A further key step is to adjust the relative orientation of the light source and the electrode.
Attaching an optical fiber directly to a metal electrode in parallel is advantageous for many
deep brain optogenetic stimulation experiments. This configuration provides an ideal
approach for guiding the optical stimulation to be directly above the recorded neuron or
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circuit, and can allow a stiff electrode to provide a mechanical guide for fiber optic insertion.
However, this approach has the drawback of adding unnecessary light exposure to the
portion of the electrode shank that is transmitting the signal and thereby enhancing artifacts.
Complete or near-complete eradication of artifacts can be achieved when using thin wire
stereotrode or tetrodes by adjusting the angle of the electrodes so that minimal laser light
strikes them directly (Fig. 3c). Preliminary data from our experiments suggest that bipolar
electrode recordings may also eliminate small amplitude optical artifacts by allowing
subtraction of signals generated close to the electrode tips.
Tissue damage (Step 16 and post-hoc analysis)
Very high light power may cause tissue damage, which can be observed post hoc as a
compressed area in the tissue at the site of light stimulation. We have observed damage to
superficial cortical tissue as a result of sustained light stimulation >100 mW mm−2.
However, light intensities < 75 mW mm−2 are sufficient to evoke spike activity. In addition,
tissue damage can be minimized using short light pulses rather than continuous illumination.
ANTICIPATED RESULTS
With careful injection parameters, viral transduction should give close to 100% efficacy in
generating populations of neurons expressing ChR2 in each injected mouse. Because AAV-
mediated ChR2 expression spreads up to several millimeters, this system works well for
preparations using combined intracellular and extracellular recordings or large extracellular
arrays in vivo. Using the AAV DIO ChR2-mCherry vector ensures 97–100% cell-type
specificity of ChR2 expression, depending on the Cre line used12. This high level of fidelity
is critical for experiments whose goal is to determine the role of specific neural populations
in brain function. Viral transduction should produce robust ChR2 expression levels
sufficient to ensure that single light pulses of ≥0.5 ms duration evoke a minimum of one
action potential from transduced neurons. Short light pulses will evoke initial spikes with
millisecond-level precision. Frequency following at higher frequencies depends in part on
cell type12, but at lower frequencies most ChR2-expressing cells will reliably spike in
response to each light pulse.
Acknowledgments
We thank members of the Tsai and Moore laboratories for discussions and comments on the paper and M.J. Higley
for help with optics. This study was supported by grants to C.I.M. from Tom F. Petersen, the NIH and the NSF, and
by the Simons Foundation Autism Research Initiative to L.-H.T. K.D. was supported by the NIH Pioneer Program.
L.-H.T. is an Investigator of the Howard Hughes Medical Institute. J.A.C. was supported by a K99 from the NIH/
NEI; M.C. and K.M. by postdoctoral fellowships from the Knut och Alice Wallenberg Foundation; M.C. by a
NARSAD Young Investigator Award; and F.Z. by an NIH NRSA.
References
1. Ascoli GA, et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the
cerebral cortex. Nat Rev Neurosci. 2008; 9:557–568. [PubMed: 18568015]
2. Connors BW, Gutnick MJ, Prince DA. Electrophysiological properties of neocortical neurons in
vitro. J Neurophysiol. 1982; 48:1302–1320. [PubMed: 6296328]
3. Kawaguchi Y, Kubota Y. GABAergic cell subtypes and their synaptic connections in rat frontal
cortex. Cereb Cortex. 1997; 7:476–486. [PubMed: 9276173]
4. Markram H, et al. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci. 2004;
5:793–807. [PubMed: 15378039]
5. McCormick DA, Connors BW, Lighthall JW, Prince DA. Comparative electrophysiology of
pyramidal and sparsely spiny stellate neurons of the neocortex. J Neurophysiol. 1985; 54:782–806.
[PubMed: 2999347]
Cardin et al. Page 10
Nat Protoc. Author manuscript; available in PMC 2013 May 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
6. Kuhlman SJ, Huang ZJ. High-resolution labeling and functional manipulation of specific neuron
types in mouse brain by Cre-activated viral gene expression. PLoS ONE. 2008; 3:e2005. [PubMed:
18414675]
7. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. Millisecond-timescale, genetically
targeted optical control of neural activity. Nat Neurosci. 2005; 8:1263–1268. [PubMed: 16116447]
8. Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance
cortical circuit performance. Nature. 2009; 459:698–702. [PubMed: 19396159]
9. Petreanu L, Huber D, Sobczyk A, Svoboda K. Channelrhodopsin-2-assisted circuit mapping of long-
range callosal projections. Nat Neurosci. 2007; 10:663–668. [PubMed: 17435752]
10. Petreanu L, Mao T, Sternson SM, Svoboda K. The subcellular organization of neocortical
excitatory connections. Nature. 2009; 457:1142–1145. [PubMed: 19151697]
11. Tsai HC, et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning.
Science. 2009; 324:1080–1084. [PubMed: 19389999]
12. Cardin JA, et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses.
Nature. 2009; 459:663–667. [PubMed: 19396156]
13. Han X, et al. Millisecond-timescale optical control of neural dynamics in the nonhuman primate
brain. Neuron. 2009; 62:191–198. [PubMed: 19409264]
14. Huber D, et al. Sparse optical microstimulation in barrel cortex drives learned behaviour in freely
moving mice. Nature. 2008; 451:61–64. [PubMed: 18094685]
15. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of
parkinsonian neural circuitry. Science. 2009; 324:354–359. [PubMed: 19299587]
16. Arenkiel BR, et al. In vivo light-induced activation of neural circuitry in transgenic mice
expressing channelrhodopsin-2. Neuron. 2007; 54:205–218. [PubMed: 17442243]
17. Marin O, Rubenstein JL. Cell migration in the forebrain. Annu Rev Neurosci. 2003; 26:441–483.
[PubMed: 12626695]
18. Wonders C, Anderson SA. Cortical interneurons and their origins. Neuroscientist. 2005; 11:199–
205. [PubMed: 15911869]
19. Saito T, Nakatsuji N. Efficient gene transfer into the embryonic mouse brain using in vivo
electroporation. Dev Biol. 2001; 240:237–246. [PubMed: 11784059]
20. Tabata H, Nakajima K. Efficient in utero gene transfer system to the developing mouse brain using
electroporation: visualization of neuronal migration in the developing cortex. Neuroscience. 2001;
103:865–872. [PubMed: 11301197]
21. Tabata H, Nakajima K. Neurons tend to stop migration and differentiate along the cortical internal
plexiform zones in the Reelin signal-deficient mice. J Neurosci Res. 2002; 69:723–730. [PubMed:
12205665]
22. Tabata H, Nakajima K. Multipolar migration: the third mode of radial neuronal migration in the
developing cerebral cortex. J Neurosci. 2003; 23:9996–10001. [PubMed: 14602813]
23. Borrell V, Yoshimura Y, Callaway EM. Targeted gene delivery to telencephalic inhibitory neurons
by directional in utero electroporation. J Neurosci Methods. 2005; 143:151–158. [PubMed:
15814147]
24. Taymans JM, et al. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and
8 in mouse brain. Hum Gene Ther. 2007; 18:195–206. [PubMed: 17343566]
25. Nathanson JL, Yanagawa Y, Obata K, Callaway EM. Preferential labeling of inhibitory and
excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus
vectors. Neuroscience. 2009; 161:441–450. [PubMed: 19318117]
26. Atasoy D, Aponte Y, Su HH, Sternson SM. A FLEX switch targets Channelrhodopsin-2 to
multiple cell types for imaging and long-range circuit mapping. J Neurosci. 2008; 28:7025–7030.
[PubMed: 18614669]
27. Livet J, et al. Transgenic strategies for combinatorial expression of fluorescent proteins in the
nervous system. Nature. 2007; 450:56–62. [PubMed: 17972876]
28. Fu H, et al. Self-complementary adeno-associated virus serotype 2 vector: global distribution and
broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther. 2003; 8:911–
917. [PubMed: 14664793]
Cardin et al. Page 11
Nat Protoc. Author manuscript; available in PMC 2013 May 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
29. Van Vliet KM, Blouin V, Brument N, Agbandje-McKenna M, Snyder RO. The role of the adeno-
associated virus capsid in gene transfer. Methods Mol Biol. 2008; 437:51–91. [PubMed:
18369962]
30. Jasnow AM, Rainnie DG, Maguschak KA, Chhatwal JP, Ressler KJ. Construction of cell-type
specific promoter lentiviruses for optically guiding electrophysiological recordings and for
targeted gene delivery. Methods Mol Biol. 2009; 515:199–213. [PubMed: 19378132]
31. Tenenbaum L, et al. Recombinant AAV-mediated gene delivery to the central nervous system. J
Gene Med. 2004; 6 (Suppl 1):S212–S222. [PubMed: 14978764]
32. Aravanis AM, et al. An optical neural interface: in vivo control of rodent motor cortex with
integrated fiberoptic and optogenetic technology. J Neural Eng. 2007; 4:S143–S156. [PubMed:
17873414]
33. Ayling OG, Harrison TC, Boyd JD, Goroshkov A, Murphy TH. Automated light-based mapping of
motor cortex by photoactivation of channelrhodopsin-2 transgenic mice. Nat Methods. 2009;
6:219–224. [PubMed: 19219033]
Cardin et al. Page 12
Nat Protoc. Author manuscript; available in PMC 2013 May 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
AAV DIO ChR2-mCherry gives Cre-dependent and cell-type-specific expression of light-
activated channels in vivo. (a) The adeno-associated viral vector AAV DIO ChR2- mCherry
carries an inverted version of ChR2 fused to the fluorescent marker mCherry8,12. This
strategy prevents ChR2 from being expressed in the absence of Cre. In the presence of Cre,
ChR2-mCherry is inverted into the sense direction and expressed from the EF-1α (EEF1A1)
promoter. EF-1α, elongation factor 1α promoter; ITR, inverted terminal repeat; pA,
poly(A); WPRE, woodchuck hepatitis B virus post-transcriptional element. (b) ChR2-
mCherry (red) is expressed specifically in PV+ interneurons (green) 6 d after injection of
AAV DIO ChR2-mCherry into the barrel cortex of an adult PV-Cre mouse. Confocal Z-
stack of two adjacent 3 μm sections. Boxed area is shown in higher magnification and detail
in c. (c) PV+ cells with ChR2-mCherry expression and typical interneuron morphology.
Confocal Z-stack of four adjacent 3 μm sections. Bar = 100 μm (b). All procedures were
conducted in accordance with the National Institutes of Health guidelines and with the
approval of the Committee on Animal Care at MIT.
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Figure 2.
Neural activity evoked in vivo by activation of cell-type-specific expression of ChR2. (a)
Schematic of the placement of the unjacketed optical fiber and extracellular electrode array
within the craniotomy (dashed line). Both the optical fiber and the electrodes were placed
several hundred micrometers from the original virus injection site (asterisk). (b) Individual
1-ms pulses of 473 nm light at 46 mW mm−2 through the optical fiber reliably evoked a
single action potential from a fast-spiking, PV+ inhibitory interneuron in the primary
somatosensory cortex in this multiunit recording. (c) A 100-ms light pulse at the same power
level evoked a sustained period of elevated firing (~220 Hz) from a fast-spiking interneuron
in this single-unit recording. (d) ChR2 can also be used in conjunction with intracellular
recordings in vivo. The traces show the membrane potential of a regular spiking, putative
excitatory neuron in a PV-Cre mouse expressing ChR2 in fast-spiking inhibitory
interneurons. Local inhibitory interneurons were repeatedly stimulated with 1-ms light
pulses while the regular spiking cell was held at varying membrane potentials. The
inhibitory post-synaptic potentials (IPSPs) resulting from light-evoked activation of
presynaptic inhibitory interneurons reversed around − 70 mV, indicating a fast, GABAA-
mediated chloride conductance.
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Figure 3.
Elimination of light-induced artifacts in recordings of the local field potential. (a) Direct
exposure of metal electrodes to the laser beam causes large electrical artifacts. These
examples are taken from recordings in a cortical site not transduced with AAV-DIO-ChR2-
mCherry. A glass pipette with a nonreflective coating was placed in the superficial cortex
~350 μm away from a tungsten electrode. The shaft and exposed tip of the tungsten
electrode were directly in the cone of blue light, as shown by the schematic to the right.
Under these conditions, pulses of laser light (68 mW mm−2; blue trace) caused a large,
repeated artifact in the LFP recording from the metal electrode (upper black trace). The
artifact started at the onset of each light pulse and lasted at least 8 ms after the end of the
light pulse (see inset). Simultaneous recordings from a glass pipette whose shaft was in the
light cone under the optical fiber did not show any light-induced artifacts (lower black
trace). (b) Similar artifacts were observed when the LFP was recorded from a cortical site
containing interneurons transduced with AAV DIO ChR2-mCherry (red dots). In this case,
the LFP recorded on the metal electrode shows a gamma oscillation induced by stimulating
the fast-spiking interneurons at 40 Hz, but the oscillation signal is obscured by the light-
induced artifact caused by the shaft of the metal electrode intersecting the laser beam (upper
trace). In contrast, the simultaneous recording from the glass electrode shows the gamma
oscillation in the absence of the artifact (middle trace), as highlighted by the filtered glass
electrode LFP (lower trace). (c) Artifacts in the metal electrode recordings can be eliminated
by changing the angle of the electrode so that the shaft does not intersect the laser beam, as
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shown in the schematic to the right. In this example, the signal on the angled metal electrode
(upper traces) agrees well with the signal on the glass electrode (lower traces).
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